ESC 2018: Findings from the REDUCE LAP-HF I Trial

Published: 10 Sep 2018

  • Views:

    Views Icon 306
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Ted Feldman (Evanston Hospital, Illinois, US)  discusses findings from the REDUCE LAP-HF I - Transcatheter interatrial shunt device for heart failure with preserved ejection fraction.

Filmed by Radcliffe Cardiology on-site at ESC 2018, Munich.